Tele: 561.316.3330
Breaking Medical Device News

Thursday, October 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeBIOTECHNOLOGYScopio Labs Receives CE Mark for X100 Microscope and Decision Support System...

Scopio Labs Receives CE Mark for X100 Microscope and Decision Support System With Full Field Peripheral Blood Smear (PBS) Application

Apr 13, 2020

Scopio Labs is a company advancing digital microscopy, today announced it has received CE mark certification for its X100 Full Field Peripheral Blood Smear (Full Field PBS) all-digital morphology analysis platform. As the first digital microscope to scan and analyze entire regions of interest from a slide in high resolution, Full Field PBS enables remote consultation and includes a computer-vision based decision support system, advancing manual microscopy into the digital age.

Scopio Labs, to date, has demonstrated accurate results on hundreds of patient samples in Tel Aviv Sourasky Medical Center – Ichilov Hospital.

Accelerating the diagnostic process by scanning and digitizing large areas of the slide in high resolution, Scopio Labs helps facilitate efficient review of digital slides and uses its built-in AI tools to compile a detailed report that can also be remotely shared with experts. Today, a significant number of hematology diagnostic tests continue to be performed using manual microscopes, increasing potential for human error, creating silos of information and delaying life-sustaining decisions.

“The clinical validation of Full Field PBS furthers our efforts to bring the digital revolution into the laboratory and improve the outcome of care across medicine,” said Itai Hayut, co-founder and CEO of Scopio Labs. “Digitization is a crucial advancement for hematology labs. With plans to provide additional assistive tools for all microscopy-based hematology diagnostics and unlock new capabilities for the industry, we are thrilled by the positive impact the Full Field PBS system can provide to our partners.”

The Full Field PBS offers an end-to-end decision-support tool for clinicians. Its digitized scans are reconstructed with cutting-edge computational photography tools at 100X equivalent magnification and at oil-immersion resolution levels. Built-in machine learning tools then pre-classify cells within the slide and create a data summary of the results. The image data, as well as the data summary, can be reviewed by experts in multiple locations – in the lab that generated the samples, and in other labs within the organization’s network. Scopio Labs platforms are scalable, suit a variety of both large and small labs, easily integrate with standard processes and are market-ready.

“The medical profession is always looking to improve patient outcomes and advance care,” said Ben-Zion Katz, Director, Hematology Laboratories at Ichilov Hospital. “However, manual microscopy requires experts to choose between platforms that offer a large field of vision or high resolution. By digitizing microscopy slides and reconstructing them into high resolution and quality scans that can be shared and analyzed remotely, Scopio Labs’ Full Field PBS offers hematologists the best of all worlds, and as a result, the opportunity to significantly reduce turnaround times and accelerate treatment initiation, giving each patient the best chance of success.”

Tel Aviv Sourasky Medical Center (Ichilov) is the largest acute care facility in Israel, managing 1.8 million patient visits per year. The institution installed the Scopio platforms in 2019, and conducted hundreds of tests on patient samples, comparing the analysis quality to standard workflows.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Luciana Borio MD is a respected physician with vast experience in advancing major regulatory and policy agendas for the United States.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy